REGISTERED NUMBER: 11392079 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

BEACONVILLE HEALTHCARE LIMITED

Page

Balance sheet

1

Notes to the financial statements

2

Fixed assets

Investments

4

82,998

82,998

Current assets

Debtors

5

446,163

442,831

Cash at bank

877

657

447,040

443,488

Creditors

Amounts falling due within one year

6

25,205

14,902

Net current assets

421,835

428,586

Total assets less current liabilities

504,833

511,584

Creditors

Amounts falling due after more than one year

7

467,674

502,265

Net assets

37,159

9,319

Capital and reserves

Called up share capital

9

3,923

3,923

Capital redemption reserve

400

400

Retained earnings

32,836

4,996

Shareholders' funds

37,159

9,319

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of comprehensive income has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 December 2025 and were signed on its behalf by:

Ms V Wilkins - Director

1.	Statutory information

Beaconville Healthcare Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 11392079. The registered office and business address is Pullman Court, Copper Street, Dorchester, Dorset, DT1 1GA.

2.	Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements

The financial statements contain information about Beaconville Healthcare Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred taxation

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Financial instruments

Basic financial instruments are initially recognised at transaction price and accounted for according to the substance of the contractual arrangement, as either financial assets, liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company, after deducting all liabilities.

At each balance sheet date, financial instruments are measured at amortised cost using the effective interest method. Any losses arising from impairment are recognised in the profit and loss account in the period to which they relate.

3.	Employees and directors

The average number of employees during the year was 2 (2024 - 2 ) .

4.	Fixed asset investments

Shares in

group

undertakings

£

Cost

At 1 April 2024

and 31 March 2025

82,998

Net book value

At 31 March 2025

82,998

At 31 March 2024

82,998

5.

Debtors: amounts falling due within one year

2025

2024

£

£

Amounts owed by group undertakings

445,175

440,855

Other debtors

988

1,976

446,163

442,831

6.

Creditors: amounts falling due within one year

2025

2024

£

£

Bank loans and overdrafts

23,195

12,988

Accruals and deferred income

2,010

1,914

25,205

14,902

7.

Creditors: amounts falling due after more than one year

2025

2024

£

£

Bank loans - 1-2 years

23,195

12,988

Bank loans - 2-5 years

69,583

38,964

Bank loans more than 5 years

374,896

450,313

467,674

502,265

Amounts falling due in more than five years:

Repayable by instalments

Bank loans more than 5 years

374,896

450,313

8.	Secured debts

The following secured debts are included within creditors:

2025

2024

£

£

Bank loans

490,869

515,253

All amounts owing to Barclays Security Trustee Limited are secured by way of debenture over the assets and undertaking of the company, containing fixed and floating charge, and negative pledge, dated 12 May 2021, but also by way of a cross guarantee over the assets of 21st Century Care (Plymouth) Ltd, its wholly owned subsidiary.

9.	Called up share capital

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

3,923

Ordinary A

£1

3,923

3,923

10.	Ultimate controlling party

The company is controlled by the director, Ms V. Wilkins, who owns 51% of the issued voting share capital.